Kenya’s President Uhuru Kenyatta has said the rate of vaccination in the country had suffered as a result of vaccine nationalism, a claim that rich countries are buying up vaccine supplies.

He told the BBC that despite Kenyan researchers being involved in developing the AstraZeneca vaccine, the lack of production facilities in the country had undermined Kenya's response to the pandemic.

"What we are now realising is that it’s not enough just to partner in terms of the research... we also want to be part of the production so that we can ensure that going forward we are never again going to be victims of the kind of vaccine nationalism that we’ve seen,” he told the BBC's Sophie Ikenye.

A large number of poorer countries, many of them in Africa relying on the global vaccine-sharing scheme Covax, have not had enough doses to vaccinate their population, according to the World Health Organization.

Less than 2% of Africa's population has been fully vaccinated.

Mr Kenyatta has been attending a three-day global education summit which he co-hosted with the UK Prime Minister Boris Johnson in London.